Results 191 to 200 of about 63,635 (266)

Association between anti-nephrin autoantibodies and disease activity in minimal change disease. [PDF]

Ann Med
Guo M, Yan L, Zhao J, Liu X, Zhang H, Li M, Zhang K, Cui J, Wang Y, Chen X, Dong Z, Li Q.   +11 more
europepmc   +1 more source

Management of Refractory Thymoma‐Associated Myasthenia Gravis With Sequential FcRn Antagonist and Complement Inhibition Combined With Resection of Pleural Dissemination

Neurology and Clinical Neuroscience, EarlyView.
ABSTRACT Myasthenia gravis (MG) associated with disseminated thymoma is often refractory to conventional treatments due to continuous autoantibody production. The optimal treatment strategy, particularly the combination of complement component 5 (C5) inhibitor, neonatal Fc receptor (FcRn) antagonist, and surgical resection in thymoma‐associated ...
Hiroyuki Takenaka, Madoka Iida, Yuki Fukami, Masahisa Katsuno   +3 more
wiley   +1 more source

Galactose‐Deficient Immunoglobulin A1 Predicts Immunoglobulin A Nephropathy Recurrence After Kidney Transplantation: A Single‐Center Retrospective Study

Organ Medicine, EarlyView.
Serum galactose‐deficient IgA1 levels at 3 and 6 months predicted recurrent IgA nephropathy after kidney transplantation. Recipients without recurrence showed a rapid decline in galactose‐deficient IgA1 after transplantation. Early identification of recurrence risk provided a potential window for targeted post‐transplant intervention.
Ronghai Deng, Wengen Chen, Xinhua Chang, Zehuan Chen, Qianyu Ye, Bowen Xu, Yifang Gao, Suxiong Deng, Xiaolin Yu, Changxi Wang, Xiangjun Liu   +10 more
wiley   +1 more source

An international consensus on screening and monitoring early-stage type 1 diabetes: A roadmap to European implementation. [PDF]

Diabetes Obes Metab
Hussain S, Tree T, Mathieu C, Klupa T, Tuomaala AK, de Wit M, Kordonouri O, Braune K, Pall J, Castano L, Besser REJ, Galhardo J, Ulivi F, Bosi E, Bogdanovic U, Alabert C, Battelino T.   +16 more
europepmc   +1 more source

Assessing Extracellular Vesicle Proteins as Predictive Biomarkers for Developing Type 1 Diabetes

PROTEOMICS, EarlyView.
ABSTRACT Plasma extracellular vesicles (EVs) are considered excellent sources for biomarker discovery since they carry signatures of their cellular origin and disease processes. In this paper, we evaluate the potential of plasma EV proteomics analysis for identifying predictive biomarkers of developing type 1 diabetes (T1D), which results from ...
Panshak P. Dakup, Lisa M. Bramer, Athena Schepmoes, Ivo Diaz Ludovico, Javier Flores, Raghavendra G. Mirmira, Bobbie‐Jo M. Webb‐Robertson, Thomas O. Metz, Emily K. Sims, Ernesto S. Nakayasu   +9 more
wiley   +1 more source

Diurnal Variation of Islet Autoantibody Titers in Established Type 1 Diabetes Suggests Restricted-Time Sampling Improves Aab Measurement and Detection

Beam C, DiMeglio L, Speake C, Boest-Bjerg K, Pearce O, Almutairi BA, Evans-Molina C, Wong FS, Long AE, Gillespie KM, James P.   +10 more
europepmc   +1 more source

Factors associated with interstitial lung disease among patients with idiopathic inflammatory myopathies. [PDF]

Rheumatology (Oxford)
Wilkerson JC, Miller FW, Bridge MF, Larson GJ, Schurman SH, Garantziotis S, Farhadi PN, Schiffenbauer A, Rider LG.   +8 more
europepmc   +1 more source

Association of PD-1 gene polymorphisms and serum soluble PD-1 levels with type 1 diabetes mellitus susceptibility in a Chinese Han cohort: a case-control study. [PDF]

Front Immunol
Zhao R, Feng X, Wang N, Wang Z, Liu J, Wang G.   +5 more
europepmc   +1 more source

Bringing early detection to life: real-world operationalization of a presymptomatic type 1 diabetes screening and monitoring pilot program. [PDF]

BMJ Open Diabetes Res Care
Demeterco-Berggren C, Ospelt E, Wright T, Rioles N, Buckingham D, Mungmode A, Ebekozien O, Byer-Mendoza C, McNamara K, Huber A, Saldana A, Jacobsen L.   +11 more
europepmc   +1 more source

Natural Anti-NMDAR1 autoantibodies associate with slowed decline of cognitive functions in Alzheimer's diseases. [PDF]

Transl Psychiatry
Zhou X.
europepmc   +1 more source